$VRCA Verrica Pharmaceuticals Inc. Insider Trading
Get free email notifications about insider trading in Verrica Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Verrica Pharmaceuticals Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Verrica Pharmaceuticals Inc. for free.
CIK Number: 0001660334
IRS Number: 463137900
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: VRCA
Company Address: 10 NORTH HIGH STREET SUITE 200 WEST CHESTER 19380
Phone number: 4349808100
Verrica Pharmaceuticals Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | VRCA | Verrica Pharmaceut ... | DAVIS A BRIAN | Chief Financial Off ... | Buy | P | 9.89 | 5,000 | 49,450 | 12,900 | 7.9 K to 12.9 K (+63.29 %) |
Mar 29 2021 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 14.75 | 739,830 | 10,912,493 | 739,830 | 0 to 739.8 K |
Mar 03 2021 | VRCA | Verrica Pharmaceut ... | Goldenberg Gary | Chief Medical Offic ... | Option Exercise | A | 14.32 | 65,000 | 930,800 | 65,000 | |
Mar 03 2021 | VRCA | Verrica Pharmaceut ... | Bonaccorso Joe | Chief Commercial Of ... | Option Exercise | A | 14.32 | 65,000 | 930,800 | 65,000 | |
Mar 03 2021 | VRCA | Verrica Pharmaceut ... | Hayes Christopher G. | Chief Legal Officer | Option Exercise | A | 14.32 | 65,000 | 930,800 | 65,000 | |
Aug 26 2020 | VRCA | Verrica Pharmaceut ... | Ballaron Craig | Director | Buy | P | 8.57 | 4,772 | 40,896 | 10,000 | 5.2 K to 10 K (+91.28 %) |
Aug 26 2020 | VRCA | Verrica Pharmaceut ... | Ballaron Craig | Director | Buy | P | 9.16 | 5,228 | 47,888 | 5,228 | 0 to 5.2 K |
Aug 21 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 9.09 | 20,000 | 181,800 | 8,099,394 | 8.1 M to 8.1 M (+0.25 %) |
Aug 19 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 8.55 | 10,000 | 85,500 | 1,481,719 | 1.5 M to 1.5 M (+0.68 %) |
Aug 18 2020 | VRCA | Verrica Pharmaceut ... | Manning Paul B | Director | Buy | P | 6.92 | 6,000 | 41,520 | 1,471,719 | 1.5 M to 1.5 M (+0.41 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | Stalfort Sean | Director | Buy | P | 6.38 | 15,700 | 100,166 | 462,110 | 446.4 K to 462.1 K (+3.52 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | Stalfort Sean | Director | Buy | P | 6.45 | 15,550 | 100,298 | 446,410 | 430.9 K to 446.4 K (+3.61 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | Stalfort Sean | Director | Buy | P | 6.38 | 15,700 | 100,166 | 462,110 | 446.4 K to 462.1 K (+3.52 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | Stalfort Sean | Director | Buy | P | 6.45 | 15,550 | 100,298 | 446,410 | 430.9 K to 446.4 K (+3.61 %) |
Aug 17 2020 | VRCA | Verrica Pharmaceut ... | DAVIS A BRIAN | Chief Financial Off ... | Buy | P | 6.24 | 7,900 | 49,296 | 7,900 | 0 to 7.9 K |